Κυριακή 7 Αυγούστου 2016

20Q: CAPD - Diagnosis and Intervention

1. Thanks for joining me for another session. Do you remember exactly where we left off? Oh, yes. We were talking about services in the schools. I think you became a bit overwhelmed when within two paragraphs, I talked about the individualized education plan (IEP), the Individuals with Disabilities Education Act (IDEA), the ICD-10 classification (H93.25), the 1973 Rehabilitation Act (Section 504 plan of accommodations), and the Response to Intervention (RTI) approach.

from #Audiology via ola Kala on Inoreader http://ift.tt/2b2bt0R
via IFTTT

900sync: Wireless for Today's Lifestyle

Today’s course will cover Starkey’s latest 900-MHz wireless system. We’ll start from the beginning with some background on the development of wireless technology, and look at the various wireless systems that are available in the hearing aid industry. Finally, we'll move into the details of Starkey’s latest 900sync technology and review updates to accessories, to software, and to product families.

from #Audiology via ola Kala on Inoreader http://ift.tt/2b2bWjB
via IFTTT

20Q: CAPD - Diagnosis and Intervention

1. Thanks for joining me for another session. Do you remember exactly where we left off? Oh, yes. We were talking about services in the schools. I think you became a bit overwhelmed when within two paragraphs, I talked about the individualized education plan (IEP), the Individuals with Disabilities Education Act (IDEA), the ICD-10 classification (H93.25), the 1973 Rehabilitation Act (Section 504 plan of accommodations), and the Response to Intervention (RTI) approach.

from #Audiology via xlomafota13 on Inoreader http://ift.tt/2b2bt0R
via IFTTT

900sync: Wireless for Today's Lifestyle

Today’s course will cover Starkey’s latest 900-MHz wireless system. We’ll start from the beginning with some background on the development of wireless technology, and look at the various wireless systems that are available in the hearing aid industry. Finally, we'll move into the details of Starkey’s latest 900sync technology and review updates to accessories, to software, and to product families.

from #Audiology via xlomafota13 on Inoreader http://ift.tt/2b2bWjB
via IFTTT

20Q: CAPD - Diagnosis and Intervention

1. Thanks for joining me for another session. Do you remember exactly where we left off? Oh, yes. We were talking about services in the schools. I think you became a bit overwhelmed when within two paragraphs, I talked about the individualized education plan (IEP), the Individuals with Disabilities Education Act (IDEA), the ICD-10 classification (H93.25), the 1973 Rehabilitation Act (Section 504 plan of accommodations), and the Response to Intervention (RTI) approach.

from #Audiology via ola Kala on Inoreader http://ift.tt/2b2bt0R
via IFTTT

900sync: Wireless for Today's Lifestyle

Today’s course will cover Starkey’s latest 900-MHz wireless system. We’ll start from the beginning with some background on the development of wireless technology, and look at the various wireless systems that are available in the hearing aid industry. Finally, we'll move into the details of Starkey’s latest 900sync technology and review updates to accessories, to software, and to product families.

from #Audiology via ola Kala on Inoreader http://ift.tt/2b2bWjB
via IFTTT

Clinical features of delayed endolymphatic hydrops and intralabyrinthine schwannoma : An imaging-confirmed comparative case series. English version.

Related Articles

Clinical features of delayed endolymphatic hydrops and intralabyrinthine schwannoma : An imaging-confirmed comparative case series. English version.

HNO. 2016 Aug 4;

Authors: Jerin C, Krause E, Ertl-Wagner B, Gürkov R

Abstract
BACKGROUND: The aim of this study was to compare the clinical history and audiovestibular function test results of patients suffering from intralabyrinthine schwannoma or delayed endolymphatic hydrops (DEH).
PATIENTS AND METHODS: Five patients diagnosed with intralabyrinthine schwannoma by magnetic resonance imaging (MRI) and five patients diagnosed with DEH by locally enhanced inner ear MRI (LEIM) were retrospectively studied.
RESULTS: All patients with intralabyrinthine schwannoma or DEH initially presented with hearing loss. Vertigo occurred in two patients with intralabyrinthine schwannoma and in all patients with DEH. While audiometry achieved poorer results for patients with intralabyrinthine schwannomas, vestibular function tests revealed normal results in about half of the patients in both groups.
CONCLUSION: Patients with intralabyrinthine schwannomas may present with clinical symptoms similar to patients suffering from other inner ear disorders such as delayed endolymphatic hydrops and they may obtain similar findings in audiovestibular function tests. High-resolution magnetic resonance imaging with locally applied contrast agent may provide evidence of both underlying pathologies.

PMID: 27492473 [PubMed - as supplied by publisher]



from #Audiology via ola Kala on Inoreader http://ift.tt/2aEoJq5
via IFTTT

Clinical features of delayed endolymphatic hydrops and intralabyrinthine schwannoma : An imaging-confirmed comparative case series. English version.

Related Articles

Clinical features of delayed endolymphatic hydrops and intralabyrinthine schwannoma : An imaging-confirmed comparative case series. English version.

HNO. 2016 Aug 4;

Authors: Jerin C, Krause E, Ertl-Wagner B, Gürkov R

Abstract
BACKGROUND: The aim of this study was to compare the clinical history and audiovestibular function test results of patients suffering from intralabyrinthine schwannoma or delayed endolymphatic hydrops (DEH).
PATIENTS AND METHODS: Five patients diagnosed with intralabyrinthine schwannoma by magnetic resonance imaging (MRI) and five patients diagnosed with DEH by locally enhanced inner ear MRI (LEIM) were retrospectively studied.
RESULTS: All patients with intralabyrinthine schwannoma or DEH initially presented with hearing loss. Vertigo occurred in two patients with intralabyrinthine schwannoma and in all patients with DEH. While audiometry achieved poorer results for patients with intralabyrinthine schwannomas, vestibular function tests revealed normal results in about half of the patients in both groups.
CONCLUSION: Patients with intralabyrinthine schwannomas may present with clinical symptoms similar to patients suffering from other inner ear disorders such as delayed endolymphatic hydrops and they may obtain similar findings in audiovestibular function tests. High-resolution magnetic resonance imaging with locally applied contrast agent may provide evidence of both underlying pathologies.

PMID: 27492473 [PubMed - as supplied by publisher]



from #Audiology via ola Kala on Inoreader http://ift.tt/2aEoJq5
via IFTTT

Stability, Survival, and Tolerability of an Auditory Osseointegrated Implant for Bone Conduction Hearing: Long-Term Follow-Up of a Randomized Controlled Trial.

Objective: To compare implant stability, survival, and soft tissue reactions for a novel (test) and previous generation (control) percutaneous auditory osseointegrated implant for bone conduction hearing at long-term follow-up of 5 years. Study Design: Single follow-up visit of a previously completed multicenter, randomized, controlled trial. Patients: Fifty-seven of the 77 participants of a completed randomized controlled trial on a new auditory osseointegrated implant underwent a single follow-up visit 5 years after implantation, which comprised implant stability measurements and collection of Holgers scores. Additionally, implant survival was recorded for all 77 patients from the original trial. Results: The test implant showed significantly higher implant stability quotient (ISQ) values compared with the control implant throughout the 5-year follow-up. Mean area under the curve of ISQ high from baseline to 5 years was 71.6 (standard deviation [SD] +/-2.0) and 66.7 (SD +/-3.4) for the test and control implant, respectively (p

from #Audiology via xlomafota13 on Inoreader http://ift.tt/2aQmbmP
via IFTTT